Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1HS5

NMR SOLUTION STRUCTURE OF DESIGNED P53 DIMER

Summary for 1HS5
Entry DOI10.2210/pdb1hs5/pdb
DescriptorCELLULAR TUMOR ANTIGEN P53 (1 entity in total)
Functional Keywordsdimer, anti-parallel beta-turn-helix, gene regulation
Biological sourceHomo sapiens (human)
Cellular locationCytoplasm. Isoform 1: Nucleus. Isoform 2: Nucleus. Isoform 3: Nucleus. Isoform 4: Nucleus. Isoform 7: Nucleus. Isoform 8: Nucleus. Isoform 9: Cytoplasm: P04637
Total number of polymer chains2
Total formula weight8217.02
Authors
Davison, T.S.,Nie, X.,Ma, W.,Li, Y.,Kay, C.,Benchimol, S.,Arrowsmith, C.H. (deposition date: 2000-12-22, release date: 2001-01-10, Last modification date: 2024-05-22)
Primary citationDavison, T.S.,Nie, X.,Ma, W.,Lin, Y.,Kay, C.,Benchimol, S.,Arrowsmith, C.H.
Structure and functionality of a designed p53 dimer.
J.Mol.Biol., 307:605-617, 2001
Cited by
PubMed Abstract: P53 is a homotetrameric tumor suppressor protein involved in transcriptional control of genes that regulate cell proliferation and death. In order to probe the role that oligomerization plays in this capacity, we have previously designed and characterized a series of p53 proteins with altered oligomeric states through hydrophilc substitution of residues Met340 or Leu344 in the normally tetrameric oligomerization domain. Although such mutations have little effect on the overall secondary structural content of the oligomerization domain, both solubility and the resistance to thermal denaturation are substantially reduced relative to that of the wild-type domain. Here, we report the design and characterization of a double-mutant p53 with alterations of residues at positions Met340 and Leu344. The double-mutations Met340Glu/Leu344Lys and Met340Gln/Leu344Arg resulted in distinct dimeric forms of the protein. Furthermore, we have verified by NMR structure determination that the double-mutant Met340Gln/Leu344Arg is essentially a "half-tetramer". Analysis of the in vivo activities of full-length p53 oligomeric mutants reveals that while cell-cycle arrest requires tetrameric p53, transcriptional transactivation activity of monomers and dimers retain roughly background and half of the wild-type activity, respectively.
PubMed: 11254385
DOI: 10.1006/jmbi.2001.4450
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

238895

건을2025-07-16부터공개중

PDB statisticsPDBj update infoContact PDBjnumon